Brief: Topline Results From Mylox-1 Trial Show Reduced Fibrosis Of Bone Marrow In Patients With Myelofibrosis

Damora Therapeutics

21/12/2023 22:14

Dec 21 (Reuters) - Galecto Inc  GLTO.O :
    * TOPLINE RESULTS FROM MYLOX-1 TRIAL DEMONSTRATE REDUCTION
IN
FIBROSIS OF THE BONE MARROW IN PATIENTS WITH MYELOFIBROSIS
    * GALECTO INC: GB2064 DEMONSTRATED TARGET ENGAGEMENT
SYSTEMICALLY
BY BINDING TO LOXL2 IN PLASMA
    * GALECTO : TOPLINE RESULTS FROM MYLOX-1 TRIAL REAFFIRM
ANTI-FIBROTIC ACTIVITY OBSERVED IN INTERMEDIATE ASSESSMENT OF
TRIAL ANNOUNCED IN SEPTEMBER 2022

Source text for Eikon:  ID:nGNX5Dp1Dl 
Further company coverage:  GLTO.O 

 ((Reuters.Briefs@thomsonreuters.com;))